£30.7M awarded for expanded Biomedical Research Centre in Birmingham

PIONEER is pleased to be supporting the Birmingham Biomedical Research Centre (BRC) in Inflammation, helping to deliver research into inflammatory diseases by enabling patient and public supported access to health data, after the centre was renewed by the National Institute of Health Research (NIHR) with increased funding totalling £30.7m.

The BRC combines world-class strengths in immunology and inflammation research and extensive experimental medicine infrastructure and is led jointly by University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. It is one of 20 NHS and University partnerships across England, who has each been awarded funding through the National Institute for Health Research, boosting growth in cities across the country.

The renewed funding will support a five-year programme between the NHS and University as core partners of Birmingham Health Partners (BHP) to better understand and treat a range of debilitating diseases for patients in Birmingham and beyond.

The Birmingham BRC will enable researchers to focus on eight areas of illness including heart disease, women’s health and common complication from inflammation. It will also enable researchers to consider new tests and biomarkers for disease, health technologies including stem cells and gene therapy, patient experience and data science.

Professor Elizabeth Sapey, Director PIONEER, Consultant in Acute & Respiratory Medicine, Director of the Institute of Inflammation and Ageing said:

“As Director of PIONEER, I am delighted that Birmingham has been awarded this greatly expanded NIHR Biomedical Research Centre. We are looking forward to working with all of the partners, accelerating innovation through access to health data.

“Research creates a better future for our patients and communities and PIONEER is proud to support important scientific breakthroughs and the discovery of new treatments. We are also proud that our patient and public oversight of all data access decisions means we have the public’s support for the projects we are involved in.”

Leave a Reply

Your email address will not be published. Required fields are marked *